Drugs / Cytochlor
Cytochlor
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00521183 | Jun 2007 → May 2014 | central nervous system neoplasm | Brian Lally | Completed | No outcome recorded |
| Phase 1 | NCT00077051 | Apr 2004 → Jul 2007 | head and neck cancer | University of Miami | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cytochlor | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00521183 ↗ |
| Known as | 5-cldc | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297275 ↗ |
| Known as | NSC-371331 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297275 ↗ |
| Modality | Small molecule | — CHEMBL4297275 ↗ |
| Route | Intravenous | “Patients receive tetrahydrouridine IV over 5 minutes followed by cytochlor IV for 3 days on week 1 and 5 days a week on weeks 2-4” NCT00077051 ↗ |